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T
he role of variability at the single-cell
level in determining population-wide
biological response is a topic of much
current interest.13 The advent of high-
throughput microscopy has provided the
technology with which individual cells
can be studied en masse and their inter-
relations, which deﬁne population level
traits, understood.4 Within the ﬁeld of bio-
nanotechnology, the development of a
plethora of nanoparticles and their testing
in biological assays has led to widespread
appreciation of the unique properties pre-
sent at the nanoscale and the need to
reassess standard metrics when it comes
to nanoparticlecell interactions.57 How-
ever, much of this work is focused on
population-averaged measurements such
as doseresponse curves, and despite
intensive eﬀorts over a decade or more,
robust, standardized protocols are still not
available.8 Knowledge of the source and
form of variation in biological responses to
nanoparticles is an obvious requirement if
we are to gain a detailed understanding
in areas such as nanomedicine911 and
nanotoxicology,12,13 where the level of drug
or toxin determines the biological output,
namely therapeutic outcome or mortality
level. Beyond these areas, the impact of
variations in cell response is still important;
for example, it is critical in determining the
level of reporter signal from intracellular
nanosensors.14,15 A reliance on population-
averagedmeasureswhich ignore cell-to-cell
variability is also prevalent in wider pharma-
cological studies. A single identifying param-
eter, z, is widely used in drug-screening
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ABSTRACT Understanding the eﬀect of variability in the interaction
of individual cells with nanoparticles on the overall response of the cell
population to a nanoagent is a fundamental challenge in bionanotechnol-
ogy. Here, we show that the technique of time-resolved, high-throughput
microscopy can be used in this endeavor. Mass measurement with single-cell
resolution provides statistically robust assessments of cell heterogeneity,
while the addition of a temporal element allows assessment of separate
processes leading to deconvolution of the eﬀects of particle supply and
biological response. We provide a speciﬁc demonstration of the approach,
in vitro, through time-resolved measurement of ﬁbroblast cell (HFF-1) death caused by exposure to cationic nanoparticles. The results show that heterogeneity
in cell area is the major source of variability with area-dependent nanoparticle capture rates determining the time of cell death and hence the form of the
exposureresponse characteristic. Moreover, due to the particulate nature of the nanoparticle suspension, there is a reduction in the particle concentration
over the course of the experiment, eventually causing saturation in the level of measured biological outcome. A generalized mathematical description of the
system is proposed, based on a simple model of particle depletion from a ﬁnite supply reservoir. This captures the essential aspects of the nanoparticlecell
interaction dynamics and accurately predicts the population exposureresponse curves from individual cell heterogeneity distributions.
KEYWORDS: nanomedicine . nanotoxicology . bionanotechnology . nanoparticle dose . nanoparticle exposure .
doseresponse characteristic . high-throughput microscopy
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assays; this is based on measurement of mean values
across a cell population and an imposed assumption
of a Gaussian distribution proﬁle for assessed metric.
Approaches of this type are inherently limited for
describing cellular heterogeneity.16
There is now a comprehensive body of work report-
ing on in vitro studies in which the complexities of
the processes through which particles arrive at the cell
membrane and interact with it (e.g., diﬀusion and
sedimentation) have been explored in detail.1719
Likewise, it is known that agglomeration of the parti-
cles, which is dependent on media content and the
functional coating on the particles, can also alter
cellular uptake.20 Given the complexity andmultiplicity
of nanoparticlecell interactions and their relation to
toxic eﬀects within the cell,21,22 we present a simplify-
ing approach that aims to describe the dose response
in terms of a dose metric relating to particle up-
take (proportional to internalized dose rather than
exposure) and a response, captured as a complete
description across the varying susceptibility of the cell
population. In a typical doseresponse experiment,
the summed response of a cell population to a range of
exposure concentration is measured. In this case, the
assay outcome is determined by a convolution of the
particle supply and uptake dynamics, which determine
the relation of exposure level to accumulated cellular
dose and the heterogeneity in cell response to this
dose. Thus, the innate biological susceptibility is not
directly apparent. However, through the adoption of
time-resolved approaches the evolution of biological
response, as an increasing dose elicits a reaction from
evermore resistant cells, can be tracked.23 Importantly,
the study of the response over increasing time intervals
as opposed to increasing exposure concentrations
allows deconvolution of supply processes and re-
sponse mechanisms and hence separation of a re-
sponse that is due to a limitation in the toxin or drug
supply from that due to an innate resistance in the cell
population. We demonstrate the application of this
approach using cationic nanoparticles (polyethylenimine-
coated quantum dots: PEI-QD) to induce death in
in vitro cultured HFF-1, ﬁbroblasts. The collection of
timemortality data allows us to quantify the time-
dependent nanoparticle supply and thus transform the
known exposure concentrations to a measure of accu-
mulated particle dose within the cells. We deliberately
concentrate on the internalized dose, i.e., we measure
the nanoparticle dose actually delivered to the cell. By
adopting this approach, we avoid the complications
which arise when trying to describe the particle deliv-
ery due to the complexities of agglomeration, sedi-
mentation, and diﬀusion dynamics in solution. From
this “global” doseresponse metric we use individual
cell responses to deconvolve uptake variability and so
extract the innate cellular susceptibility to membrane
disruption by the charged nanoparticles.
RESULTS AND DISCUSSION
Standard End-Point ConcentrationResponse Measurement.
The exposureresponse curve measured after 24 h
exposure of fibroblasts to a range of PEI-QD concen-
trations is shown in Figure 1A. This displays the classic
sigmoid curve of increasing cell mortality in response
to the nanoparticle concentration in the medium.24 In
this case, the highly charged, PEI-coated, CdSe quan-
tum dots (PEI-QDs) cause death through disruption of
cellularmembranes,25 an example of which is shown in
Figure 1B (see the Supporting Information for further
information). Electron microscopy analysis of the size
distribution of the particles which interact with the cell
membrane is shown in Figure 1C. Individual particles
with a size range of 3080 nm can be seen attached to
the cell surface in the electronmicrograph of Figure 1D.
Long-term studies of cytotoxicity of Cd-containing
QDs generally attribute cytotoxicity to a Cd2þ leakage
from the core.26 However, in our study, all the experi-
ments were done within a 24 h time period, and the
chemical stability of Cd-based quantum dots, at nano-
molar concentrations, over this time frame is well
documented.27 We are conﬁdent, therefore, that the sur-
face chemistry of the particles is the dominant factor
determining the eﬀects observed. The literature on the
toxic eﬀect of amine-modiﬁedparticles on cells highlights
lipid membrane disruption as a key determinant,25 and
our TEM micrographs (see the Supporting Information)
conﬁrm signiﬁcant membrane damage at 3 and 24 h
following PEI-QD exposure. This corresponds well with
DRAQ7 signals that are seen within minutes of expo-
sure at particular concentrations of PEI-QDs and which
are due to membrane permeabilisation.
Figure 1. (A) Exposureresponse curve for HFF-1 cells
exposed to PEI-QDs for a 24 h duration. Data was collected
from 81 image frames encompassing >4000 cells. (B) Elec-
tronmicrograph of a cell section showing severemembrane
disruption due to the high cationic charge of the PEI-QDs.
(C) Size distribution of PEI-QDs at the cell surface measured
from electron microscopy images (n = 93). (D) Electron
micrograph of a cell section showing individual PEI-QDs
on the cell membrane.
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Measurements such as those presented in Figure 1
provide a quantitative benchmark for standardization
and comparison of diﬀerent studies; however their
power to inform on underlying biological processes is
limited as they only provide end-point information on
the mean response of a population of cells. For exam-
ple, the data in Figure 1 shows that on average 50% of
cells die within 24 h when exposed to a 4.5 nM
concentration of PEI-QDs. While this deﬁnes the LD50
point the cause of the observed cell mortality is still
obscure; do 50% of the population remain alive be-
cause they are resilient and able to withstand the
eﬀects induced by the nanoparticles or because they
have acquired a lower particle dose? Themetric is unable
to distinguish between supply and response variation
and so cannot help in answering this question.
Time-Dependent ExposureResponse Measurement. In a
typical in vitro experiment, the cell population is
exposed to a known solution particle concentration,
C, of nanoparticles, for a fixed time, t. The total available
number of nanoparticles administered to the culture
media is then, n0 = CV, where V is the volume of solu-
tion. In traditional doseresponse studies of chem-
ical agents or biological pathogens the dose delivered
is assumed to be a linear function of time, described by
an average arrival rate, λ, per particle. Using this
approach, the number of particles or dose taken up
by a cell population, ndose(t)= CVλt. If the cell response
is proportional to this particle dose then it follows
Haber's rule;27 i.e., it is a function of the product of
concentration and duration of exposure. In dose
response theory, the variability of the cell response is
included using a probability distribution function (PDF)
of cell susceptibility parametrized by a mean number,
μ, of particles to elicit a response (with standard
deviation, σ). The cumulative frequency of this prob-
ability distribution (CDF) charts the doseresponse
curve,28 the summed response of the cell population
as the particle dose increases. Assuming a normal
distribution for the susceptibility PDF, the time-dependent
response curve due to nanoparticle accumulation is
given by
R(t) ¼
Z ndose(t)
¥
1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2πσ2
p exp
n  μﬃﬃﬃﬃ
2σ2
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 2
dn
¼ 1
2
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(1)
Thus, measurement of the time-differentiated cellular
response, dR(t)/dt can provide the cell susceptibility
distribution.
Timemortality curves for the HFF-1 cells over a
range of PEI-QD exposures of 024 h duration are
shown in Figure 2. For the 18 nM exposure concentra-
tion the supply of particles is such that even the most
resistant cells acquire a lethal dose. At lower exposure
concentrations the % cell death plateaus well before
the 24 h point, and extrapolation of the data indicates
that low susceptibility cells are unlikely to reach the
required particle dose threshold for cell death. Inter-
preting these results in terms of eq 1: the saturation
in % cell death at later times is due to diminishing
increments in the integration across the susceptibility
PDF as the value of ndose no longer linearly increases
with time; i.e., there is a limitation to particle supply.
Particle Supply from a Fixed Reservoir. To confirm that
the limitation in levels of cell death is caused by limited
nanoparticle availability, we repeated the time
mortality assay with an added replenishment step.
After 18 h of exposure, the medium containing nano-
particles was removed and fresh medium (of identical
volume and with the same particle concentration) was
introduced for the remainder of the assay. The results,
shown in Figure 3, clearly highlight the effect of supply
depletion as the renewal of particle supply produces an
immediate increase in cell death. Similarly, experi-
ments at fixed concentration but increasing exposure
solution volumes also produced increased values
of % cell death due to greater number of particles
Figure 2. Timemortality curves for HFF-1 cells exposed to
PEI-QDs, at varying concentrations, over a 24 h period. Data
were collected from 81 image frames encompassing >3000
cells.
Figure 3. Timemortality curves for HFF-1 cells exposed to
PEI-QDs with replenishment of culture medium after 18 h
(indicatedbydashedgray line). For t>18h the two curves at
each exposure concentration plot the % cell death with
(higher values) andwithout (lower values) replenishment of
the medium.
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(see Supporting Information). It is clear that in these
experiments there is nonlinear particle accumulation
over time and so Haber's rule is not applicable. Satura-
tion of the number of particles internalized by cells is a
common observation in nanoparticle uptake experi-
ments. If the internalization mechanism is receptor
mediated endocytosis, then this phenomenon can
occur due to limitation of the available receptors
during the course of the experiment.29 However, in
our experiments, in which unspecific cell death occurs
due to accumulation of particles at the membrane, it is
limitation in particle supply which leads to dose satura-
tion. This is confirmed by measurements of particle
accumulation onto the bare surface of the culture dish,
which show the same saturation of fluorescence signal
(see the Supporting Information). The problem of
particle depletion is particularly acute in nanoparticle
assays because loading over a fewhours leads to a total
accumulated dose in the picomole range (105107
particles per cell in ∼106 cells3033). Typically, in ex-
posure volumes of mL at nM concentrations (picomole
quantities) a major fraction of available particles are
therefore removed from solution, and hence, depletion
of particle supply will be a common occurrence.
The time dependence of toxicity has been well
studied within in vivo settings,34 especially within
ecological toxicity assessement.35 In general, the accu-
mulation of small-molecule drugs is characterized by a
two-way ﬂow, in and out of the cell,36 as molecules can
diﬀuse across the membrane according to the direc-
tion of the concentration gradient or are actively
removed from the cell by molecular eﬄux pumps.37
This is in contrast to the general situation when using
nanoparticles, where cellular accumulation is in eﬀect a
one-way valve. Nanoparticles are internalized by en-
docytic processes and encapsulated in membrane-
bound vesicles, and while there is some exocytosis,38
this is limited and the general trend is for long-term
accumulation of particles.39
Extraction of a Global ExposureResponse Metric. To
mathematically describe the nonlinear particle supply,
we consider the cellular accumulation of particles from
a fixed initial reservoir (the initial exposure number, n0),
assuming that the accumulation rate is proportional to
the remaining number of available particles, n0 ndose
(see the Supporting Information for full details). This
provides a simple expression for the total accumulated
particle number across the cell population
ndose(t) ¼ ηCV(1  et=τ) (2)
where η is a constant describing the capture cross-
section of cells, i.e., it accounts for the fraction of
particles that attach to cells rather than to the culture
well surface. The parameter τ is the average accumula-
tion time per particle, is constant with respect to t and
ndose, and is determined by the multiplicity of supply
side mechanisms, e.g., diffusion, sedimentation, and
agglomeration. In effect, τ provides a single metric
describing the average behavior of the particle disper-
sion and allows us to simplify the description of dose
accumulation. Given that the experimental measure to
which eq 2 is compared is an internalized dose (i.e., we
measure the outcome rather than the mechanisms of
particle supply), this parametrization of the particle
dynamics is a valid approach. Using eq 2, the time and
concentration dependence of cellular response seen in
Figure 2 can be transformed to show % cell death as a
function of accumulated dose. This is shown in Figure 4A
for a τ value of 5.5 h; in this case, η is assumed to be∼1
due to the high cell confluency. As the cell response is
now plotted as a function of accumulated dose it is
independent of the route to this accumulation; thus,
the profile is a “global” measure, unaffected by the
intricacies of particle supply.
The shape of the response curve is now determined
solely by the biological susceptibility to the nano-
particles, and thus, its diﬀerential provides the sus-
ceptibility probability distribution of the population
(Figure 4B); i.e., it describes the population-averaged
vulnerability of the cells. We demonstrate the utility
of this link between response curve and cell suscept-
ibility through a study of the toxicity of the PEI-QDs in
primary and immortalized ﬁbroblasts. Figure 5A shows
the measured cell death over a 24 h period for the
HFF-1 cells and for a population of primary human
Figure 4. (A) Percent cell death as a function of total
accumulated dose in the cell population for 3 (magenta
symbols), 4.5 (red), 6 (green), and 18 nM (blue) exposure
concentrations. (B) Cell population susceptibility distribu-
tion obtained by diﬀerentiation of the doseresponse
curve in (A).
Figure 5. (A) Percent cell death as a function of time for
HFF-1 cells (blue) and primary ﬁbroblasts (red) exposed to
an 18 nM concentration of PEI-QDs. (B) Cell population
susceptibility distribution obtained by diﬀerentiation of
the timeresponse curves in (A).
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dermal ﬁbroblasts. There is a clear increase in cell death
in the primary population at a given time. An enhanced
susceptibility of primary derived cells to cationic par-
ticles has been well documented and is related to the
increased mitochondrial activity in these cells com-
pared to immortalized cell lines.40,41 Here, we are able
to quantify this diﬀerence in toxicity by extracting the
susceptibility distribution directly from the temporal
dose response curve (Figure 5B). This indicates a mean
susceptibility of 32 nM h for primary cells compared to
85 nM h for the HFF-1 cells with associated variance of
40% and 82%, respectively. Thus, primary cells display
a more homogeneous as well as an enhanced suscept-
ibility to the PEI-QDs. In this example, the ability to
extract the innate biological susceptibility leads to a
clear indication of diﬀerent biological mechanisms
driving the response of primary and immortalized cells.
This stems from “the Warburg eﬀect”, which describes
the altered metabolism of cancer cells leading to
increased reliance on aerobic glycolysis rather than
mitochondrial oxidative phosphorylation to generate
the energy needed for cellular processes.42 The data in
Figure 5B provides a quantiﬁcation of the increased
tolerance of immortalized cells to cationic particles,
produced by this reduced reliance on mitochondrial
processes.
Susceptibility of Individual Cells. The biological suscept-
ibility profile shown in Figure 4B is obtained from
population wide measurement of the fraction of cells
which respond at each dose value and is based on a
calculation of the total accumulated dose, across all
cells (n>4000). To understand the role of individual cell
heterogeneity in determining this population response,
we use high-throughput microscopy to directly analyze
cell-to-cell variability in dose and response. The time
dependence of dose accumulation in single cells was
tracked up to the point of cell death by surrogate
measurement of the total QD fluorescence. Represen-
tative data from nine individual cells chosen from the
measured population of over 4000, exposed to a range
of PEI-QD concentrations, are shown in Figure 6AD.
Two general points can be made from inspection of
these data: (i) there is a “threshold” dose range atwhich
the accumulated particle dose is sufficient to trigger
cell death; (ii) the rate of particle accumulation in
individual cells varies greatly for the same exposure
concentration and it is this variable dose accumulation
which primarily determines the time of death.
Equation 2 indicates that the total acquired dose is
dependent upon the cross-sectional area available for
nanoparticle capture, as described by the parameter η.
At the single-cell level, this implies a cell-area depen-
dent dose with larger cells possessing a larger capture
cross-section and hence accumulating particles more
rapidly. To assess the validity of this hypothesis, we
plotted the predicted dose accumulation for individual
cells based on eq 2 (Figure 6AD), where for single
cells η = Acell/Awell. The cell area (Acell) was obtained
from themicroscopy images, and the value of τwas set
to 5.5 h as indicated by the data in Figure 4. There is
close agreement of the data with eq 2 strongly corro-
borating the hypothesis of a cell area dependent
uptake. The clear correlation in the time of cell death,
td to the inverse of cell area is shown in Figure 6E
(Pearson correlation index = 0.92).
The plots in Figure 6AD display two independent
sources of heterogeneity in cellnanoparticle interac-
tion dynamics. There is variability in the acquired dose
at a ﬁxed time point due to the cell area dependent
accumulation (dose heterogeneity) and there is an
innate variability in the ability of individual cells to
survive a given dose (response heterogeneity). To
assess the relative importance of these we plot the
QD dose which triggers cell death versus the time of
Figure 6. Time dependence of relative particle dose in individual cells obtained frommeasurement of total ﬂuorescence per
cell for exposure concentrations of (A) 3, (B) 4.5, (C) 6, and (D) 18 nM; solid black lines indicate model ﬁts (using eq 2). (E)
Correlation plot of inverse cell area  concentration versus time of cell death, td (colors used for diﬀerent exposure
concentrations as per Figure 5AD).
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death (Figure 7A, n = 89). The dose and response
heterogeneities are represented in Figure 7A by histo-
grams of time of death and dose at death, respectively.
Having quantiﬁed the cellular heterogeneity distribu-
tions we compare them in Figure 7B to the population
distribution of Figure 4B. The comparison is made
using a normalized histogram variable of x/mean(x)
to allow assessment of the relative variance of the
proﬁles and clearly shows that it is the cell area
variability which is the dominant factor in determining
the population level characteristic. (For amathematical
assessment of the role of these sources of hetero-
geneity, see the Supporting Information.)
Relating Individual Cell and Population Traits. Having
established the primary driver of cell response at the
individual cell level, this information can be used to
construct a complete model of cell-nanoparticle inter-
action with an ab initio description of the population
response based on single cell studies. To do this, we
use themeasured cell area heterogeneity (n = 700) and
mean dose at death, nth (indicated in Figure 7A) to
calculate the distribution in time of death, td, using a
reformulation of eq 2:
td ¼ τ ln 1  nth
CV
:
Awell
Acell
 1
(3)
Cumulative integration of the td distribution across
a time interval t then provides a predicted value of the
% cell death at t. The results of this analysis are
presented in Figure 8 together with the directly mea-
sured experimental data (replotted from Figure 2). The
model is thus completely deﬁned by experimentally
determined parameters and its validity conﬁrmed by
the close match of the simulation to the data over a
wide range of exposure concentration and duration.
CONCLUSIONS
In summary, we have used high-throughput micro-
scopy to understand the link between individual
cells and the population wide response to nano-
particles. This allows deconstruction of the standard
exposureresponse metric to separate the roles of
particle supply and biological response and highlights
the sources of cell heterogeneity which lead to re-
sponse variability. While we demonstrate this ap-
proach using ﬂuorescent, quantum dots the mathe-
matical formulism which we present is ultimately used
to predict the time dependence of cell death; thus in
this respect it is independent of the type of nanopar-
ticle used and hence has wide applicability. Tools such
as this are important for future studies in the ﬁelds of
nanomedicine and nanotoxicology to aid in the pro-
gression from description of nanoparticle interactions
Figure 7. (A) Dot plot of time of cell death and the QD ﬂuorescence (surrogate for particle dose) at that time (n = 89). The
data are also shown in histogram form with the horizontal dashed line indicating the mean ﬂuorescence at time of
death. (B) Normalized histograms of population susceptibility (black line), cell area (red bars), and dose at threshold
(blue bars).
Figure 8. Measured (red curve) and predicted (blue bars)
timemortality curves for HFF-1 cells exposed to PEI-QDs at
(A) 3, (B) 4.5, (C) 6, and (D) 18 nM concentrations. Predicted
values based on measured cell area distribution and eqs 2
and 3.
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to quantiﬁcation of the biological processes and me-
chanisms that underpin them. In certain subﬁelds such
as cancer therapeutics43 and genotoxicity,44 the ability
to understand individual cell response rather than the
population average is essential as the “rare” cell can
dictate the end result.
METHODS
Materials, Cell Culture, and Cell Lines. Human foreskin fibroblast
cells (HFF-1, ATCC SCRC-1041) and primary human dermal
fibroblasts were obtained from the American type culture
collection (ATCC, Manassas, VA). The HFF-1 cells were cultured
(37 C; 5%CO2) in DMEMmedium supplementedwith 15% fetal
bovine serum (FBS), 4 mM L-glutamine, 1 mM sodium pyruvate,
and 1% penicillin (50 IU/mL)/streptomycin (50 μg/mL). The
primary fibroblasts were cultured in fibroblast basal medium
supplemented with a low serum growth kit containing 2%
serum (ATCC). Cells were grown in 75 cm2 flasks placed in a
humidified incubator at 37 C with 5% CO2 before use. Quan-
tumdots (QDs) with a CdSe core and a ZnS shell synthesized in a
coordinating solvent tri-n-octylphosphine oxide (TOPO, 99%,
Aldrich) in accordance with previously published procedures.45
The QDs were synthesized in a single-mode CEM Discover
microwave reactor operating at 300 W, 2.45 GHz. Cadmium
oxide (CdO, 99.99%, Alfa Aesar, 0.0514 g, 0.4 mM) along with
tetradecylphosphonic acid (TDPA, 98%, Alfa Aesar, 0.2232 g,
0.8 mM) and TOPO (3.7768 g, 9 mM) were heated with con-
tinuous stirring in a 125 mL glass flask. The solution was heated
for 15 min at approximately 300 C under argon (Ar) flow. A
selenium stock solution (Aldrich, 99%, 0.0411 g, 0.5 mM) dis-
solved in 2.4mL (2 g) of tri-n-octylphosphine (TOP, 99%, Aldrich)
was injected at 270 C, and Q-Dots were allowed to grow for
150 s. A ZnS shell was grown on the CdSe cores by injecting a
mixture of Zn and S precursors: 1.6 mL (12 mM) of dimethylzinc
(DMZ-1 M in heptane, Aldrich), 0.42 mL (2 mM) of hexamethyl-
disilathiane (HMDS, Aldrich), and 6.3 mL (14 mM) of TOP. The
reaction mixture was heated for 30 min at 200 C. The quantum
yield of the Q-Dots increased on annealing the particles at a
temperature of 100 C for a period of 2 h.
The QDs were surface modiﬁed with high molecular weight
branched polyethylenimine (BrPEI) (Aldrich, MW 25000). Brieﬂy,
a 10 mg/mL solution of BrPEI in chloroform was mixed with
an equal volume of 24 μM QDs. The mixture, kept at room
temperature, was tumbled overnight. PEI-QDs were precipi-
tated from the mixture by addition of excess cyclohexane
(Sigma-Aldrich, 0.99%) and suspended in deionized water.
Excess BrPEI was extracted from the aqueous QDs solution by
addition of fresh chloroform, which was phase-separated from
water.
The zeta potential and the hydrodynamic diameter of the
PEI-QDs when suspended in phosphate buﬀer (PB) at a con-
centration of 21 nM was measured using a Zetasizer Nano ZS
(Malvern Corp, Worcestershire, UK) using a 633 nm laser. The
PEI-QD diameter was also measured from scanning electron
micrographs, performed when the PEI-QDs at a concentration
of 3 nM were suspended in 2 mL of DMEM cell culture media
and 15% FBS and supplemented with 1% penicillin G/strepto-
mycin. The zeta potential and the hydrodynamic diameter of
the PEI-QDs when suspended in phosphate buﬀer were mea-
sured at þ18.6 ( 5.67 mV and 27.68 ( 5.67 nm, respectively,
and the PEI-QDs a mean diameter of 51.39 ( 17.30 nm when
measured from scanning electron micrographs.
Cytotoxicity Analysis. Cytotoxicity was quantified usingDRAQ7
(Biostatus Ltd., UK) staining, which is a far-red fluorescent
necrotic dye which was kindly gifted by Biostatus Ltd. DRAQ7
is excluded from viable cells and, hence, only stains the nuclei in
dead and/or cell membrane permeabilized cells as it passively
diffuses through the damaged cytoplasmic and nuclear mem-
branes and eventually binds with AT-rich repeats in DNA.
HFF-1 cells were seeded at a concentration of 70000 cells
per well in Greiner Bio One Cellstar tissue culture six-well plate
for 24 h. The PEI QDs were vortexed for 5 s, and 2, 3, 4.5, 6, or
18 nM concentrations of PEI-QDs and 3 μM concentration
of DRAQ7 were placed in 2 mL of complete DMEM medium.
The cells were washed twice in serum-free medium and in-
cubated with 2 mL of complete DMEM medium containing PEI
QDs and DRAQ7. High-throughput, time-lapse-based experi-
ments were performed within 510 min of dosing using the In-
Cell Analyzer 2000 microscope (GE Healthcare, UK). Images
were obtained hourly for 24 h from 81 ﬁelds with each ﬁeld
containing approximately 4050 cells, meaning a total of
over 4000 cells were imaged at each time point. Cells were
imaged at 20magniﬁcation in three channels: the DRAQ7 and
the PEI-QDs in ﬂuorescence mode with excitation/emission
wavelengths of 633/655 nm and 350/568 nm, respectively.
Brightﬁeld images were also obtained using transmitted white
light. At the end of the time lapse experiments, the cells were
dosedwith 10 μMPEI-QDs in 2mL ofmedia with 0.5 h exposure,
which caused 100% cell death in each well. An additional set of
imageswas collected fromwhich ameasure of the total number
of cells in each well was obtained. Cell death was quantiﬁed by
the automatedmeasure of the DRAQ7signals at each time point
using In-Cell Developer Toolbox software (GE Healthcare, UK)
and was displayed as a percentage of the total cells within each
well. In addition to this, a separate time lapse was performed
from 0 to 43 h to conﬁrm the stability of the DRAQ7 signals
between 0 and 43 h.
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